Immunohistochemical assessment of formalin-fixed tumor tissues showed that the expression of ki67 proliferation marker was markedly decreased in all three treatment groups compared with the vehicle-treated controls, with the highest reduction in the SAM + 25(OH)D cohort (Fig. 2e). This evidence concerns the gene MKI67 and neoplasm.